By Abigail Townsend
Date: Wednesday 01 May 2024
(Sharecast News) - Pfizer raised its full-year earnings forecast on Wednesday, on the back of solid demand for its non-Covid products.
The US drugs giant, which saw sales and profits rocket during the pandemic due to strong demand for its Covid-19 vaccine Comirnaty, said revenues fell 20% in the first quarter...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news